Holen Sie sich die Stockscreener-App
283.49
1.28%
-3.69
Handel nachbörslich:
283.49
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$287.18
Offen:
$288.57
24-Stunden-Volumen:
1.32M
Relative Volume:
1.44
Marktkapitalisierung:
$10.08B
Einnahmen:
$2.40B
Nettoeinkommen (Verlust:
$587.79M
KGV:
18.24
EPS:
15.5461
Netto-Cashflow:
$682.87M
1W Leistung:
-0.73%
1M Leistung:
+12.22%
6M Leistung:
+37.76%
1J Leistung:
-24.39%
1-Tages-Spanne:
$278.81
$288.57
1-Wochen-Bereich:
$274.33
$289.45
52-Wochen-Spanne:
$185.00
$387.75
Factset Research Systems Inc Stock (FDS) Company Profile
Firmenname
Factset Research Systems Inc
Sektor
Telefon
(203) 810-1000
Adresse
45 GLOVER AVENUE, NORWALK, CT
Compare FDS vs SPGI, CME, ICE, MCO, NDAQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FDS
Factset Research Systems Inc
|
283.49 | 9.89B | 2.40B | 587.79M | 682.87M | 15.55 |
SPGI
S P Global Inc
|
418.80 | 120.90B | 15.73B | 5.15B | 5.56B | 15.81 |
CME
Cme Group Inc
|
269.80 | 94.27B | 6.76B | 4.26B | 4.33B | 11.72 |
ICE
Intercontinental Exchange Inc
|
154.73 | 84.96B | 12.93B | 3.99B | 4.24B | 6.8684 |
MCO
Moodys Corp
|
484.96 | 82.75B | 7.87B | 2.50B | 2.75B | 13.95 |
NDAQ
Nasdaq Inc
|
97.02 | 53.47B | 8.27B | 1.91B | 2.00B | 3.3193 |
Factset Research Systems Inc Stock (FDS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-17 | Fortgesetzt | BofA Securities | Underperform |
| 2025-12-17 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-22 | Hochstufung | UBS | Neutral → Buy |
| 2025-09-12 | Hochstufung | Rothschild & Co Redburn | Sell → Neutral |
| 2025-06-26 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2025-03-21 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-10-09 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2024-10-02 | Eingeleitet | Evercore ISI | In-line |
| 2024-08-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-05-30 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-04-11 | Eingeleitet | Wolfe Research | Underperform |
| 2024-03-22 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-12-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-08-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-06-15 | Fortgesetzt | BofA Securities | Neutral |
| 2023-05-15 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2023-05-09 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-28 | Hochstufung | Redburn | Sell → Neutral |
| 2023-01-12 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-08-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-05-17 | Eingeleitet | Redburn | Sell |
| 2022-03-30 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-14 | Hochstufung | Northcoast | Sell → Neutral |
| 2021-09-30 | Hochstufung | UBS | Sell → Neutral |
| 2021-08-25 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-07-08 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-06-11 | Herabstufung | Northcoast | Neutral → Sell |
| 2020-06-01 | Fortgesetzt | Oppenheimer | Perform |
| 2019-11-22 | Eingeleitet | Jefferies | Hold |
| 2019-09-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-16 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2019-06-27 | Herabstufung | Goldman | Neutral → Sell |
| 2018-12-07 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2018-12-07 | Fortgesetzt | Credit Suisse | Neutral |
| 2017-12-05 | Herabstufung | Northcoast | Buy → Neutral |
| 2017-11-08 | Eingeleitet | Goldman | Neutral |
| 2017-09-21 | Hochstufung | Northcoast | Neutral → Buy |
| 2017-01-10 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2016-09-27 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2016-08-26 | Eingeleitet | Macquarie | Neutral |
| 2016-07-12 | Eingeleitet | Credit Suisse | Outperform |
| 2016-03-22 | Eingeleitet | Sterne Agee CRT | Neutral |
| 2016-03-16 | Herabstufung | Stifel | Buy → Hold |
| 2016-03-10 | Herabstufung | UBS | Neutral → Sell |
| 2015-12-08 | Bestätigt | Stifel | Buy |
| 2015-11-10 | Eingeleitet | Cantor Fitzgerald | Hold |
Alle ansehen
Factset Research Systems Inc Aktie (FDS) Neueste Nachrichten
FactSet Research Systems Inc. stock underperforms Friday when compared to competitors - MarketWatch
Ryman Hospitality Properties, Inc. (REIT) Stock 12‑Month Price Target Cut to $134.71, Implies 8% Upside - TradingView
Suncrete, Inc. Stock 12‑Month Price Target Cut to $23.5, Implies 25% Upside - TradingView
Satellos Bioscience Inc. Stock 12‑Month Price Target Cut to $21.78, Implies 122% Upside - TradingView
Gemini Space Station, Inc. Stock 12‑Month Price Target Cut to $6.06, Implies 41% Upside - TradingView
Blaize Holdings, Inc. Stock 12‑Month Price Target Cut to $1.8, Implies 54% Upside - TradingView
Performance Food Group Company Stock 12‑Month Price Target Raised to $130.27, Implies 25% Upside - TradingView
Nu Holdings Ltd. Stock 12‑Month Price Target Raised to $18.01, Implies 29% Upside - TradingView
KinderCare Learning Companies, Inc. Stock 12‑Month Price Target Cut to $4.13, Implies 15% Downside - TradingView
Brinker International, Inc. Stock 12‑Month Price Target Raised to $272, Implies 14% Upside - TradingView
Alto Neuroscience, Inc. Stock 12‑Month Price Target Raised to $37.56, Implies 16% Upside - TradingView
American Eagle Outfitters, Inc. Stock 12‑Month Price Target Cut to $19.5, Implies 20% Upside - TradingView
Sana Biotechnology, Inc. Stock 12‑Month Price Target Cut to $9.38, Implies 155% Upside - TradingView
Satellos Bioscience Inc. Stock 12‑Month Price Target Cut to $21.92, Implies 123% Upside - TradingView
Jefferson Capital, Inc. Stock 12‑Month Price Target Raised to $27.29, Implies 26% Upside - TradingView
Eikon Therapeutics, Inc. Stock 12‑Month Price Target Cut to $24.6, Implies 138% Upside - TradingView
Erasca, Inc. Stock 12‑Month Price Target Raised to $23, Implies 29% Upside - TradingView
Caribou Biosciences, Inc. Stock 12‑Month Price Target Cut to $11.86, Implies 636% Upside - TradingView
Candel Therapeutics, Inc. Stock 12‑Month Price Target Raised to $20.88, Implies 77% Upside - TradingView
Applied Materials, Inc. Stock 12‑Month Price Target Raised to $654.18, Implies 22% Upside - TradingView
York Space Systems Inc. Stock 12‑Month Price Target Cut to $31.78, Implies 176% Upside - TradingView
Credicorp Ltd. Stock 12‑Month Price Target Raised to $436.51, Implies 16% Upside - TradingView
SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView
SCNX Q2'26 Earnings: EPS estimate is (0.09) USD - TradingView
NSPR Q2'26 Earnings: EPS estimate is (0.20) USD - TradingView
NRXP Q2'26 Earnings: EPS estimate is (0.11) USD - TradingView
HMR Q2'26 Earnings: EPS estimate is 0.05 USD - TradingView
BJ Q2'26 Earnings: revenue estimate is 5.97B USD - TradingView
POSCO HOLDINGS INC. Stock 12‑Month Price Target Cut to $77.63, Implies 37% Upside - TradingView
Lear Corporation Stock 12‑Month Price Target Cut to $149, Implies 21% Upside - TradingView
Knife Riv Holding Co. Stock 12‑Month Price Target Cut to $92.71, Implies 41% Upside - TradingView
Credicorp Ltd. Stock 12‑Month Price Target Raised to $437.02, Implies 16% Upside - TradingView
SoundThinking, Inc. Stock 12‑Month Price Target Cut to $12.67, Implies 53% Upside - TradingView
SolarEdge Technologies, Inc. Stock 12‑Month Price Target Cut to $35.35, Implies 10% Upside - TradingView
Jefferson Capital, Inc. Stock 12‑Month Price Target Raised to $26.57, Implies 23% Upside - TradingView
A.P. MollerMaersk A/S Class A Stock 12‑Month Price Target Raised to DKK 13949.01, Implies 17% Downside - TradingView
FactSet Research Systems Inc (FDS) Stock Up 3.3% and Still Under - GuruFocus
FactSet Research Systems Inc. Announces Quarterly Dividend of $1.16 (NYSE:FDS) - MarketBeat
FactSet Research Systems Inc. stock outperforms competitors on strong trading day - MarketWatch
BitGo Holdings, Inc. Stock 12‑Month Price Target Cut to $11.44, Implies 129% Upside - TradingView
Jack In The Box Inc. Stock 12‑Month Price Target Raised to $19.38, Implies 3% Upside - TradingView
Tencent Holdings Ltd Stock 12‑Month Price Target Cut to HKD 676.07, Implies 46% Upside - TradingView
SBS Stock 12‑Month Price Target Cut to $6.86, Implies 34% Upside - TradingView
North American Construction Group Ltd. Stock 12‑Month Price Target Cut to $19.62, Implies 28% Upside - TradingView
Darling Ingredients Inc. Stock 12‑Month Price Target Raised to $81.57, Implies 29% Upside - TradingView
Alto Neuroscience, Inc. Stock 12‑Month Price Target Raised to $37.11, Implies 27% Upside - TradingView
First Tracks Biotherapeutics, Inc. Stock 12‑Month Price Target Raised to $63.38, Implies 37% Upside - TradingView
Kura Oncology, Inc. Stock 12‑Month Price Target Raised to $32, Implies 222% Upside - TradingView
Keurig Dr Pepper Inc. Stock 12‑Month Price Target Raised to $36.27, Implies 23% Upside - TradingView
Cisco Systems, Inc. Stock 12‑Month Price Target Raised to $139.62, Implies 13% Upside - TradingView
Enovix Corporation Stock 12‑Month Price Target Cut to $13.5, Implies 185% Upside - TradingView
Finanzdaten der Factset Research Systems Inc-Aktie (FDS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
1.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):